These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8718575)

  • 21. Vaccination strategies using viable carrier systems against intracellular pathogens.
    Hess J; Szalay G; Miko D; Gentschev I; Goebel W; Ladel CH; Kaufmann SH
    Behring Inst Mitt; 1994 Dec; (95):67-79. PubMed ID: 7755511
    [No Abstract]   [Full Text] [Related]  

  • 22. [The promotion of immunizations: a discussion of vaccinal schedules].
    del Rey Calero J
    An R Acad Nac Med (Madr); 1993; 110(1):75-98; discussion 99-103. PubMed ID: 8238823
    [No Abstract]   [Full Text] [Related]  

  • 23. 32nd annual meeting of the European Society for Pediatric Infectious Diseases in Dublin, Ireland.
    Butler K
    Pediatr Infect Dis J; 2014 Nov; 33(11):1180-2. PubMed ID: 25144802
    [No Abstract]   [Full Text] [Related]  

  • 24. A small jab - a big effect: nonspecific immunomodulation by vaccines.
    Benn CS; Netea MG; Selin LK; Aaby P
    Trends Immunol; 2013 Sep; 34(9):431-9. PubMed ID: 23680130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in cellular therapy: 6th International Symposium on the clinical use of cellular products, March 24 and 25, 2011, Erlangen, Germany.
    Ullrich E; Bosch J; Aigner M; Voelkl S; Kroeger I; Hoffmann P; Kreutz M; Dudziak D; Gerbitz A
    Cancer Immunol Immunother; 2012 Mar; 61(3):433-43. PubMed ID: 22200930
    [No Abstract]   [Full Text] [Related]  

  • 26. Prime-boost immunization strategies for infectious diseases.
    McShane H
    Curr Opin Mol Ther; 2002 Feb; 4(1):23-7. PubMed ID: 11883691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA vaccines for emerging infectious diseases: what if?
    Whalen RG
    Emerg Infect Dis; 1996; 2(3):168-75. PubMed ID: 8903226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial: Some challenges for future investigations in infectious diseases and clinical immunology.
    Wolff SM
    J Infect Dis; 1974 Jul; 130(1):85-8. PubMed ID: 4601182
    [No Abstract]   [Full Text] [Related]  

  • 29. mRNA vaccine technology for infectious diseases and beyond.
    Hao P; Li X; Li X; Zhong W
    Sci China Life Sci; 2024 Oct; 67(10):2267-2270. PubMed ID: 38965140
    [No Abstract]   [Full Text] [Related]  

  • 30. Bacterial toxin's DNA vaccine serves as a strategy for the treatment of cancer, infectious and autoimmune diseases.
    Behzadi E; Halabian R; Hosseini HM; Fooladi AAI
    Microb Pathog; 2016 Nov; 100():184-194. PubMed ID: 27671283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine adjuvants: is the pipeline clogged?
    Leitner WW
    Immunotherapy; 2012 Jun; 4(6):565-7. PubMed ID: 22788122
    [No Abstract]   [Full Text] [Related]  

  • 32. Introduction: The role of inflammation, autoimmune disease and infectious agents in development of leukaemia and lymphoma.
    Rosenquist R
    J Intern Med; 2008 Dec; 264(6):512-3. PubMed ID: 19017175
    [No Abstract]   [Full Text] [Related]  

  • 33. 1991 Mack Forster Award Lecture. HLA and disease: from epidemiology to immunotherapy.
    de Vries RR
    Eur J Clin Invest; 1992 Jan; 22(1):1-8. PubMed ID: 1559538
    [No Abstract]   [Full Text] [Related]  

  • 34. Microbial pathogenesis: mechanisms of infectious disease.
    Carruthers VB; Cotter PA; Kumamoto CA
    Cell Host Microbe; 2007 Oct; 2(4):214-9. PubMed ID: 18005739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunopathology in the infectious process].
    Semenov BF
    Vestn Akad Med Nauk SSSR; 1979; (11):85-93. PubMed ID: 160148
    [No Abstract]   [Full Text] [Related]  

  • 36. New adjuvants for human vaccines.
    Mbow ML; De Gregorio E; Valiante NM; Rappuoli R
    Curr Opin Immunol; 2010 Jun; 22(3):411-6. PubMed ID: 20466528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automated mass immunization of poultry: the prospect for nonreplicating human adenovirus-vectored in ovo vaccines.
    Avakian AP; Poston RM; Kong FK; Van Kampen KR; Tang DC
    Expert Rev Vaccines; 2007 Jun; 6(3):457-65. PubMed ID: 17542759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease.
    Mortellaro A; Ricciardi-Castagnoli P
    Immunol Cell Biol; 2011 Mar; 89(3):332-9. PubMed ID: 21301476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccines work.
    Nat Commun; 2018 Apr; 9(1):1666. PubMed ID: 29691393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designer probiotics for the prevention and treatment of human diseases.
    Chua KJ; Kwok WC; Aggarwal N; Sun T; Chang MW
    Curr Opin Chem Biol; 2017 Oct; 40():8-16. PubMed ID: 28478369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.